Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity
This study investigated the binding affinities of danazol to rat androgen, glucocorticoid, progesterone, and estrogen receptors and correlated these findings with the drug's known biological activity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (28)
- Adrenal function during chronic danazol administration via openalex
- ANTIGONADOTROPIN (DANAZOL) IN THE TREATMENT OF ENDOMETRIOSIS via openalex
- Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data via openalex
- Contraceptive properties of Danazol. via openalex
- Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Danazol--a synthetic steroid derivative with interesting physiologic properties via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol inhibits steroidogenesis in the rat testis in vitro via openalex
- Danazol-testosterone combination: A potentially effective means for reversible male contraception. A preliminary report via openalex
- Hormonal changes associated with Danazol therapy via openalex
- Isolation, synthesis, and biological activity of five metabolites of danazol via openalex
- Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol) via openalex
- Pituitary gonadotropin inhibitory activity of danazol via openalex
- Progestational activity of danazol in the human female subject via openalex
- The effect of danazol in sexual precocity via openalex
- The effect of danazol on anterior pituitary function via openalex
- The use of an impeded androgen--danazol--in the management of benign breast disorders via openalex
- doi:10.1016/0014-5793(77)80577-2 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1021/bi00802a019 via openalex
- doi:10.1210/endo-91-3-738 via openalex
- W6716385964 via openalex
- W6755495115 via openalex
- doi:10.1016/b978-1-4832-3033-7.50001-5 via openalex
- doi:10.1210/jcem-35-4-522 via openalex
- doi:10.1126/science.181.4100.659 via openalex
- doi:10.1095/biolreprod10.4.438 via openalex
- doi:10.1007/bf03289420 via openalex
Cited by (50)
- Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells 2017
- Progestins for the Treatment of Endometriosis: An Update 2010
- Progestins for the Treatment of Endometriosis: An Update: 2010
- Efectos del danazol y hemisuccinato de danazol sobre la presión de perfusión y resistencia vascular 2010
- Local application of danazol-loaded hyaluronic acid hydrogel to endometriosis in a rat model 2006
- Treatment of endometrial hyperplasia with a danazol-releasing intrauterine device: a prospective study 2004
- A benefit-risk assessment of medical treatment for uterine leiomyomas 2002
- Danazol mimics antigestagen action in first trimester termination of pregnancy 2001
- Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding 1999
- Hormone replacement therapy following hysterectomy for endometriosis 1998
- Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas 1997
- Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium 1997
- Pain recurrence: a quality of life issue in endometriosis 1995
- Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository 1995
- Leukocyte subpopulation changes in rats with autotransplanted endometrium and the effect of danazol 1995
- [3H]dexamethasone binding activity in liver microsomes is modulated differently by 17 alpha-alkylated androgens and testosterone in vivo 1995
- In utero virilization by danazol: Effects on adrenal steroidogenesis 1995
- Goserelin (Zoladex) versus danazol for endometriosis: the North American experience 1994
- Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes 1994
- Induction of true precocious puberty by neonatal treatment with danazol in female rats 1993
- The effects of fetal exposure to danazol 1992
- Estrogen binding capacity in cytosol fraction of human uterine cervix: effect of estrogen and anti-estrogens 1992
- Medical treatment of mild endometriosis associated with infertility 1991
- Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: interaction with the effect of naloxone 1991
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes 1991
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes 1991
- The use of danazol as a treatment of endometriosis 1991
- Endometriosis 1990. Current treatment approaches 1990
- Comparison of the pharmacology of nafarelin and danazol 1990
- Cyclic pelvic pain 1990
- Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis 1989
- Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations 1988
- New therapy for endometriosis 1988
- Immunosuppressive effects of danazol in vitro 1987
- Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors 1987
- Pelvic Endometriosis 1987
- Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol 1986
- Inhibition of gonadotropin-releasing hormone receptors in rat anterior pituitary monolayer cell cultures by danazol 1986
- Cytoplasmic and nuclear estrogen binding capacity in the rat uterus during treatment with danazol and testosterone 1986
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro 1986
- Gynecologic Problems of Adolescence 1985
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up 1985
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1985
- Ultrastructural changes in endometriotic tissue during danazol treatment 1985
- Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment 1984
- Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project 1984
- Short-term effects of danazol on endometrial histology 1984
- Changes in the SHBG concentration during danazol treatment 1984
- Endocrine effects of danazol in the treatment of endometriosis 1984
- Danazol binding to steroid receptors in human uterine endometrium 1984
Source provenance
- openalex
- last seen: 2026-05-14T06:17:32.558309+00:00
- pubmed
- last seen: 2026-10-08T21:58:54.395363+00:00